Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
4.410
-0.010 (-0.23%)
Nov 20, 2024, 4:00 PM EST - Market closed
Humacyte Market Cap
Humacyte has a market cap or net worth of $567.43 million as of November 21, 2024. Its market cap has increased by 127.63% in one year.
Market Cap
567.43M
Enterprise Value
626.49M
1-Year Change
127.63%
Ranking
Category
Stock Price
$4.41
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $567.43M, an increase of 356.47%. That is a compound annual growth rate of 46.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 567.43M | 92.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 582.00M |
| CureVac | 578.73M |
| Varex Imaging | 576.96M |
| AnaptysBio | 574.49M |
| Tectonic Therapeutic | 572.88M |
| Simulations Plus | 567.70M |
| Mineralys Therapeutics | 567.36M |
| Axogen | 563.31M |